{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:54:33Z","timestamp":1789872873207,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brazilian Journal of Otorhinolaryngology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bjorl.2023.03.009","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T07:57:43Z","timestamp":1680854263000},"page":"101272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy of different oral H1 antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4981-2627","authenticated-orcid":false,"given":"Dongdong","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanling","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiting","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0363-8459","authenticated-orcid":false,"given":"Yuanxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjorl.2023.03.009_bib0005","first-page":"108","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis","volume":"8","author":"Wise","year":"2018","journal-title":"Int Forum Allergy Rhinol."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0010","first-page":"S1","article-title":"Clinical practice guideline: allergic rhinitis","volume":"152","author":"Seidman","year":"2015","journal-title":"Otolaryngol Head Neck Surg."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0015","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bjorl.2023.03.009_bib0020","series-title":"Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022)","article-title":"Chapter 6: choosing effect measures and computing estimates of effect","author":"Higgins","year":"2022"},{"key":"10.1016\/j.bjorl.2023.03.009_bib0025","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2217\/thy.09.1","article-title":"Rupatadine 10 and 20 mg are effective and safe in the treatment of perennial allergic rhinitis after 4 weeks of treatment: a randomized, double-blind, controlled trial with loratadine and placebo","volume":"6","author":"Kowalski","year":"2009","journal-title":"Therapy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0040","first-page":"27","article-title":"Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial","volume":"4","author":"Marmouz","year":"2011","journal-title":"J Asthma Allergy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.alit.2018.08.011","article-title":"Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: a double-blind, randomized, multicenter, placebo-controlled clinical trial","volume":"68","author":"Okubo","year":"2019","journal-title":"Allergol Int."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0050","first-page":"31","article-title":"A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Lukat","year":"2013","journal-title":"J Asthma Allergy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0055","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1398-9995.2008.01668.x","article-title":"A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis","volume":"63","author":"Fantin","year":"2008","journal-title":"Allergy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2217\/thy.10.40","article-title":"Rupatadine 10 mg in adolescent and adult symptom relief of perennial allergic rhinitis","volume":"7","author":"Molina","year":"2010","journal-title":"Therapy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2165\/00044011-199816060-00001","article-title":"Efficacy and tolerability comparison of ebastine 10 and 20 mg with loratadine 10 mg: a double-blind, randomised study in patients with perennial allergic rhinitis","volume":"16","author":"Davies","year":"1998","journal-title":"Clin Drug Investig."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0070","first-page":"56","article-title":"A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis","volume":"14","author":"Hampel","year":"2004","journal-title":"J Investig Allergol Clin Immunol."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000077357","article-title":"Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study","volume":"133","author":"Ratner","year":"2004","journal-title":"Int Arch Allergy Immunol."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2500\/108854199778553046","article-title":"Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis","volume":"20","author":"Casale","year":"1999","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0085","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0091-6749(99)70070-9","article-title":"Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis","volume":"104","author":"Howarth","year":"1999","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0090","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2222.2000.00914.x","article-title":"Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis","volume":"30","author":"Van Cauwenberge","year":"2000","journal-title":"Clin Exp Allergy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaci.2004.05.070","article-title":"Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis","volume":"114","author":"Bachert","year":"2004","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000331329","article-title":"The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion (the CIRANO study)","volume":"158","author":"Guilemany","year":"2012","journal-title":"Int Arch Allergy Immunol."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2222.2003.01596.x","article-title":"The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial","volume":"33","author":"Noonan","year":"2003","journal-title":"Clin Exp Allergy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0110","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1398-9995.2007.01374.x","article-title":"Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis","volume":"62","author":"Pradalier","year":"2007","journal-title":"Allergy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0115","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1398-9995.2009.02115.x","article-title":"Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study","volume":"64","author":"Bousquet","year":"2009","journal-title":"Allergy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2500\/aap.2013.34.3668","article-title":"Randomized controlled trial of desloratadine for persistent allergic rhinitis: correlations between symptom improvement and quality of life","volume":"34","author":"Bousquet","year":"2013","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0125","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/cea.12780","article-title":"Pathogenesis of rhinitis","volume":"46","author":"Eifan","year":"2016","journal-title":"Clin Exp Allergy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.iac.2011.05.003","article-title":"Antihistamine therapy in allergic rhinitis","volume":"31","author":"Hoyte","year":"2011","journal-title":"Immunol Allergy Clin North Am."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12948-021-00158-5","article-title":"Prescription rate and treatment patterns for allergic rhinitis from 2010 to 2018 in South Korea: a retrospective study","volume":"19","author":"Son","year":"2021","journal-title":"Clin Mol Allergy."},{"issue":"Suppl 100","key":"10.1016\/j.bjorl.2023.03.009_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/all.12531","article-title":"Update on rupatadine in the management of allergic disorders","volume":"70","author":"Mullol","year":"2015","journal-title":"Allergy."},{"key":"10.1016\/j.bjorl.2023.03.009_bib0145","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/jcm8091338","article-title":"Platelet-activating factor (PAF) in allergic rhinitis: clinical and therapeutic implications","volume":"8","author":"Mu\u00f1oz-Cano","year":"2019","journal-title":"J Clin Med."}],"container-title":["Brazilian Journal of Otorhinolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869423000344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869423000344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:39:23Z","timestamp":1761723563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1808869423000344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1808869423000344"],"URL":"https:\/\/doi.org\/10.1016\/j.bjorl.2023.03.009","relation":{},"ISSN":["1808-8694"],"issn-type":[{"value":"1808-8694","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of different oral H1 antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Brazilian Journal of Otorhinolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjorl.2023.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associa\u00e7\u00e3o Brasileira de Otorrinolaringologia e Cirurgia C\u00e9rvico-Facial. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101272"}}